Effectiveness of drug to improve natriuretic peptide levels for chronic heart failure
Monday, November 9, 2015 - 19:15
in Health & Medicine
Medical researchers randomly assigned 456 patients with worsening chronic HF and reduced left ventricular ejection fraction (a measure of how well the left ventricle of the heart pumps with each beat) to receive placebo or 1 of 4 daily target doses of the medication vericiguat for 12 weeks.